• Diseases of interest: breast, lung, pancreatic cancers, neurodegenerative diseases
  • Platforms: proteomics, metabolomics, epigenomics, immunobiology, whole genome manipulation, gene-editing (CRISPR-Cas9 and shRNA), single-cell transcriptomics (scRNA-seq/snRNA-seq), transgenic and Cas9 mouse models of human diseases, cell imaging, protein, DNA and virus manipulations, high through-put screening strategies
  • Pre-clinical trials, metronomic dosing, small animal imaging
  • Innovation through technology development and refining
  • Dissemination of new knowledge: peer-reviewed publications, invited plenary speaker, academic seminar speaker, public outreach
  • Mentoring and training of future scientist and medical doctors. Leadership and career development
  • Education of stakeholders: people with diseases, their families and friends, community and policy makers
  • Resource acquisition and management